Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BioscanR
AddedFeb 17, 2024
UpdatedJun 18, 2026
BioscanR

BioscanR

Seed

BioscanR: Personal health monitoring system using FDA-approved sensors for early detection, aiding preventative healthcare.

HQ
Tampa, FL, US
Founded
2014
Overview
Compare
Fundraising
Employees

BioscanR's mission is to enhance preventative healthcare by offering a personal health monitoring system that uses FDA-approved wearable sensors and software algorithms. Their services target chronic disease patients and those needing continuous, temporary health monitoring, providing early warnings for potentially critical health issues.

BioscanR has made significant strides in integrating advanced technology with healthcare, aiding doctors in extending their reach and improving patient outcomes. By focusing on early detection and continuous monitoring, BioscanR has positively impacted the lives of medically challenged patients.

BioscanR - Similar Companies

AffirmXH logo

AffirmXH

affirmxh.com

BioIntelliSense logo

BioIntelliSense

BioSense logo

BioSense

thebiosense.com

Clinicai logo

Clinicai

Biometry logo

Biometry

mybiometry.com

BioSensys logo

BioSensys

HealthSnap logo

HealthSnap

Dynosense logo

Dynosense

dynosense.com

Biorasis logo

Biorasis

BioSens8 logo

BioSens8

biosens8.com

BioSensics logo

BioSensics

biosensics.com

Biosenix logo

Biosenix

Scanit Technologies logo

Scanit Technologies

Pulsewave logo

Pulsewave

Injectsense logo

Injectsense

injectsense.com

BioscanR - Quick Facts

Who are BioscanR's competitors?

Companies similar to BioscanR include AffirmXH, BioIntelliSense, BioSense and Clinicai.

When was BioscanR founded?

BioscanR was founded in 2014.

Where is BioscanR's headquarters located?

BioscanR's headquarters is located in Tampa, FL, US.

When was BioscanR's last funding round?

BioscanR's most recent funding round was for $20k (USD) in July 2014.

How much has BioscanR raised to-date?

As of Jul 7, 2014, BioscanR has raised a total of $20k (USD).

How many employees does BioscanR have?

BioscanR has 6 employees as of Feb 4, 2024.

BioscanR - Classification

Ownership
  • Private
Technology
  • AI
  • Analytics
  • HealthTech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Health Monitoring
Tags
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities